| Title |
Author(s) |
Journal |
Issue Date |
Type |
|
Human Immunodeficiency Virus Type 1 (cross-) resistance to non-nucleoside reverse transcriptase inhibitors currently under development as microbicides
|
Selhorst, P.; Vazquez, A. C.; Terrazas-Aranda, K.; Michiels, J.; Vereecken, K.; Heyndrickx, L.; Weber, J.; Quiñones-Mateu, M. E.; Ariën, K. K.; Vanham, G.
|
Antimicrobial Agents and Chemotherapy |
2011
|
Article
|
|
The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV -2 isolates
|
Ariën, K. K.; Abraha, A.; Quiñones-Mateu, M. E.; Kestens, L.; Vanham, G.; Arts, E. J.
|
Journal of Virology |
2005
|
Article
|
|
Role of baseline pol genotype in HIV-1 fitness evolution
|
Weber, J.; Rangel, H. R.; Chakraborty, B.; Marotta, M. L.; Valdez, H.; Fransen, K.; Florence, E.; Connick, E.; Smith, K. Y.; Colebunders, R. L.; Landay, A.; Kuritzkes, D. R.; Lederman, M. M.; Vanham, G.; Quiñones-Mateu, M. E.
|
Journal of Acquired Immune Deficiency Syndromes |
2003
|
Article
|
|
A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression
|
Quiñones-Mateu, M. E.; Ball, S. C.; Marozsan, A. J.; Torre, V. S.; Albright, J. L.; Vanham, G.; van der Groen, G.; Colebunders, R. L.; Arts, E. J.
|
Journal of Virology |
2000
|
Article
|